The Multifactorial Pathogenesis of Calciphylaxis: A Case Report.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
07 Jun 2021
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 10 6 2021
Statut: epublish

Résumé

BACKGROUND Calciphylaxis is a rare and lifethreatening syndrome characterized by small vascular calcifications, which lead to the occlusion of blood vessels and painful skin lesions with tissue necrosis. Although the disease can develop in a population without kidney failure, it is typically detected in patients receiving dialysis, with an increasing frequency ranging from 1% to 4%. Therefore, the disease is also known as calcific uremic arteriolopathy. The prognosis in patients with coexisting chronic kidney disease is very poor, with a 1-year mortality rate of up to 80%. Numerous risk factors for calciphylaxis have been described, such as obesity, diabetes mellitus, female sex, White race, overuse of calcium and vitamin D supplements, and vitamin K deficiency. The disease is often accompanied by disorders such as hyperphosphatemia, elevated parathyroid hormone level, and a deficiency of natural calcification inhibitors, such as fetuin-A and matrix Gla protein. However, not all patients with calciphylaxis have the abnormalities described above, suggesting that the pathogenesis of calciphylaxis is multifactorial and unfortunately still uncertain. CASE REPORT We report a case of calciphylaxis in a 52-year-old White woman with multiple comorbidities and on chronic hemodialysis treatment, who presented with severe subcutaneous painful nodules and necrotic ulcers on both legs. CONCLUSIONS Although the prognosis of this rare and underrecognized disease is poor, an early diagnosis and interdisciplinary treatment including pain relief, wound care, appropriate nutritional support, correction of mineral parameters, administration of sodium thiosulphate, and adequate hemodialysis therapy can improve patient quality of life.

Identifiants

pubmed: 34097671
pii: 930026
doi: 10.12659/AJCR.930026
pmc: PMC8197444
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e930026

Références

Perm J. 2011 Spring;15(2):85-7
pubmed: 21841931
N Engl J Med. 2018 May 03;378(18):1704-1714
pubmed: 29719190
Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21
pubmed: 20716935
J Clin Aesthet Dermatol. 2008 Jul;1(2):38-41
pubmed: 21103322
Am J Kidney Dis. 2015 Jul;66(1):133-46
pubmed: 25960299
Can Med Assoc J. 1961 Sep 30;85:770-6
pubmed: 13749961
Kidney Blood Press Res. 2013;37(4-5):346-59
pubmed: 24247072
J Clin Aesthet Dermatol. 2013 May;6(5):41-4
pubmed: 23710271
J Am Acad Dermatol. 2007 Apr;56(4):569-79
pubmed: 17141359
Int J Nephrol. 2011 Feb 24;2011:701603
pubmed: 21423552
Cutis. 2018 Dec;102(6):395-400
pubmed: 30657805
J Nephrol. 2011 Mar-Apr;24(2):142-8
pubmed: 21337312
Cases J. 2008 Sep 23;1(1):178
pubmed: 18811973
Clin J Am Soc Nephrol. 2008 Jul;3(4):1139-43
pubmed: 18417747

Auteurs

Marta Turek (M)

Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

Joanna Stępniewska (J)

Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

Jacek Różański (J)

Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH